PARP inhibitors also have the capacity to activate the cGAS-STING pathway in immune cells, thereby inducing anti-tumor immunity by effectively exterminating cancer cells and promoting the release of tumor-derived DNA (105). This evidence concerns the gene STING1 and cancer.